AstraZeneca unveils Phase III kidney treatment results
In a Phase III trial, Farxiga reportedly showed reduction in the risk of kidney failure, and cardiovascular (CV) or renal death, in CKD patients.
Archives for September 15, 2020
Merck expands its HPAPI and ADC manufacturing capabilities, capacity
Merck's life science business division last week announced a US$65m expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.
Valneva to create ‘major UK vaccine facility’ as part of UK COVID-19 vaccine deal
Valneva SE has announced a vaccine partnership with the UK Government for its inactivated COVID-19 vaccine, covering up to 190 million doses.
Vaxart's oral COVID-19 tablet vaccine to enter clinical trials
Vaxart will start a Phase 1 clinical trial for its oral COVID-19 vaccine candidate, having received Investigational New Drug (IND) clearance.
Thermo Fisher addresses the growing need for more flexible, scalable biologics development
Thermo Fisher Scientific has opened a new bioprocessing collaboration center (BCC) adjacent to its biologics manufacturing facility in St Louis, Missouri.